Dąbek, B. 2023. Apalutamide as a new option for postponing metastatic disease in hormone-resistant patients with biochemical recurrence in prostate cancer. OncoReview. 13, 1(49) (Apr. 2023), 24-26. DOI:https://doi.org/10.24292/01.OR.131317323.